Strados Labs key facts
as of Oct 2026- Developer of a medical device designed to transform respiratory disease management with continuous lung sound monitoring.
- Strados Labs is valued at approximately $37.5M as of Oct 2026, set at its later-stage round, Jan 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $21.1M across 4 recorded rounds; the latest was Debt ($585K) in May 2022.
- Notable investors include US National Science Foundation, MassChallenge, SOSV, MedTech Innovator, HAX — 31 tracked in total.
- Strados Labs has filed 5 Form Ds with the SEC since 2019, most recently Jun 2022 ($585K sold to 12 investors).
- Status: Privately Held (backing).
Valued at $37.5M at its later-stage round, Jan 2026. Nothing has traded since.
- ·The complete investor list: 31 names
- ·Watch Strados Labs: the Monday email on marks, rounds and moves
Strados Labs funding rounds
4 roundsWho backs Strados Labs
31+Strados Labs valuation
Strados Labs was valued at $37.5 million at its later-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Strados Labs raised?
Strados Labs has raised $21.1 million in total; 4 of its rounds are on record, from 2019 on. The largest on record was a $585,000 debt round in May 2022.
Strados Labs has filed 5 Form Ds with the SEC since 2019, most recently in Jun 2022 ($585,000 sold to 12 investors).
Strados Labs investors
31 investors are on record for Strados Labs, including US National Science Foundation, MassChallenge, SOSV and MedTech Innovator. By type, the record holds 8 venture capital firms. The debt round in May 2022 drew 12 investors.
About Strados Labs
Developer of a medical device designed to transform respiratory disease management with continuous lung sound monitoring. The company's device is connected with a continuous breathing sensor that collects respiratory data, for data analysis, enabling doctors to connect with asthma and chronic obstructive pulmonary disease patients and to monitor their respiratory status, including frequency of coughs, wheezes, as well as the duration of inhalation and exhalation remotely.
- Sector
- Healthcare
- HQ
- Philadelphia, PA, United States
- Founded
- 2016
- Employees
- 48
- Website
- stradoslabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.